AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dppmet 50+500 Tablet

Prescription Icon
Prescription Required

Marketer

Razenta pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Dppmet 50+500 Tablet

Metformin/pioglitazone 50mg/500mg tablets manage elevated blood glucose in type 2 diabetes patients by combining two active ingredients. This dual action helps prevent severe diabetic complications like vision loss and kidney impairment, potentially lowering heart attack and stroke risk. This medication may be prescribed independently or alongside other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering current health, blood glucose readings, and concomitant medications. Consuming the tablet with food minimizes gastrointestinal upset. Consistent daily dosing is crucial for efficacy; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regime is vital for diabetes control. Common side effects include nausea, diarrhea, vomiting, abdominal discomfort, headache, and pharyngitis. Hypoglycemia is a potential risk, particularly when combined with insulin or sulfonylureas; patients should be educated on its recognition and management. This medication isn't suitable for all patients. Prior to use, inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation. Potential drug interactions exist; disclose all medications to your physician for safety. Alcohol should be limited due to its hypoglycemic effects. Your doctor will monitor renal function and blood glucose throughout treatment.

Uses of Dppmet 50+500 Tablet

Managing type 2 diabetes

Major Benefits of Dppmet 50+500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Dppmet 50+500 Tablet with a meal.

Common Side effects of Dppmet 50+500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Dppmet 50+500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Dppmet 50+500 Tablet with a meal.

How Dppmet 50+500 Tablet works:

Dppmet 50+500 tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production, improves insulin utilization, and lessens liver glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Dppmet 50+500 Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Dppmet 50+500 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Dppmet 50+500 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Dppmet 50+500 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Dppmet 50+500 Tablets. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Dppmet 50+500 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Dppmet 50+500 Tablet :

Should you forget to take your Dppmet 50+500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dppmet 50+500 Tablet

LabelValue
Developing Good Habits No.
Type of Therapy Diabetes Management

FAQs on Dppmet 50+500 Tablet

Dppmet 50+500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. It helps control blood sugar when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Dppmet 50+500 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Dppmet 50+500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Dppmet 50+500 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Dppmet 50+500 tablets is unsafe due to the increased risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA – Metformin-associated lactic acidosis), is a potential side effect of Dppmet 50+500 Tablet. This occurs due to excessive blood lactic acid. Because it's rare, metformin is avoided in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms appear, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Dppmet 50+500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Dppmet 50+500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Patients allergic to Dppmet 50+500 Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining alcohol and Dppmet 50+500 tablets is unsafe and may heighten the risk of lactic acidosis.
Dppmet 50+500 Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA – Metformin-associated lactic acidosis). This rare side effect is a reason to avoid metformin in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Dppmet 50+500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Dppmet 50+500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Dppmet 50+500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients allergic to Dppmet 50+500 Tablet components or excipients should not use it. Its use is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Dppmet 50+500 Tablets is unsafe due to the increased risk of lactic acidosis.
Dppmet 50+500 Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Dppmet 50+500 Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplementation with vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Dppmet 50+500 Tablet
181
MRP 210
13% off